| Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma (NCT01212549) | University of Ioannina | 2009-02-01 |
| Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control (NCT00663650) | Queen's University | 2008-08-01 |
| Basal Cell Carcinoma Recurrence After Mohs Surgery (NCT00882791) | Northwestern University | 2008-05-01 |
| The Impact of Total Body Skin Examination on Skin Cancer Detection (NCT00765193) | Medical University of Graz | 2008-05-01 |
| Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma (NCT00985829) | Shahid Beheshti University of Medical Sciences | 2008-01-01 |
| Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma (NCT01015898) | Shahid Beheshti University of Medical Sciences | 2008-01-01 |
| Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up (NCT00988455) | Shahid Beheshti University of Medical Sciences | 2008-01-01 |
| Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions (NCT01403480) | Rambam Health Care Campus | 2008-01-01 |
| Effect of the Subconscious on Mohs Micrographic Surgery (NCT00374062) | Northwestern University | 2007-12-01 |
| Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) (NCT00581425) | The University of Texas Health Science Center, Houston | 2007-12-01 |
| Photochemical Tissue Bonding (NCT00586040) | Massachusetts General Hospital | 2007-09-01 |
| Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery (NCT00793169) | Northwestern University | 2007-09-01 |
| Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery (NCT00578214) | Mayo Clinic | 2007-03-01 |
| Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo (NCT00574392) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |
| Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. (NCT00601185) | Memorial Sloan Kettering Cancer Center | 2006-02-14 |
| Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors (NCT00449358) | Assuta Hospital Systems | 2006-02-01 |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma (NCT00108121) | Peplin | 2005-03-01 |
| Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage (NCT00314756) | Wake Forest University | 2005-03-01 |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma (NCT00108134) | Peplin | 2005-03-01 |
| An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants (NCT02100111) | Hoffmann-La Roche | 2005-01-01 |
| A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence (NCT00129519) | Graceway Pharmaceuticals, LLC | 2004-01-01 |
| Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer (NCT00472459) | Galderma R&D | 2003-07-25 |
| Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum (NCT00046189) | National Cancer Institute (NCI) | 2003-04-07 |
| A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma (NCT00189241) | MEDA Pharma GmbH & Co. KG | 2001-02-01 |
| Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma (NCT00472108) | Galderma R&D | 2000-12-01 |
| PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma (NCT00472043) | Galderma R&D | 2000-10-01 |
| Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma (NCT00473343) | Galderma R&D | 2000-09-01 |
| Optical Biopsy of Human Skin in Conjunction With Laser Treatment (NCT00540566) | University of California, Irvine | 1999-06-01 |
| The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases (NCT00005660) | National Cancer Institute (NCI) | 1977-10-01 |
| A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base (NCT00463359) | University of Glasgow | |
| Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease (NCT00535080) | Galderma R&D | |
| Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. (NCT00049959) | QLT Inc. | |
| Evaluating In Vivo OCT Imaging for Periocular Basal Cell Carcinoma (NCT01603810) | Maidstone & Tunbridge Wells NHS Trust | |
| Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) (NCT03070691) | Novartis Pharmaceuticals | |